Literature DB >> 9198250

Regulation of the tissue factor gene.

N Mackman1.   

Abstract

Tissue factor is a cellular receptor that initiates blood coagulation. The TF gene is constitutively expressed in some extravascular cell types and is inducibly expressed in several vascular cell types, including monocytes, vascular endothelial cells and vascular smooth muscle cells. Functional studies indicate that Sp1 controls basal TF gene expression. A distal enhancer (-227 to -172) containing two AP-1 sites and an NF-kappa B site mediates induction of the human TF promoter in monocytic cells and endothelial cells. Similarly, two AP-1 sites (-220 to -200) regulate induction of the murine TF promoter in fibroblast-like cells. In contrast, proximal enhancers in the human TF (-109 to -59) and rat (-103 to -80) TF promoters containing Egr-1 and Sp1 sites mediate induction in epithelial-like cells and vascular smooth muscle cells, respectively. These results suggest that cell type-specific pathways regulate TF gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9198250

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  39 in total

1.  Lipopolysaccharide induction of tissue factor expression in rabbits.

Authors:  J Erlich; C Fearns; J Mathison; R J Ulevitch; N Mackman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Acid sphingomyelinase plays a critical role in LPS- and cytokine-induced tissue factor procoagulant activity.

Authors:  Jue Wang; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2019-07-01       Impact factor: 22.113

3.  Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor.

Authors:  Maria Loreto Bravo; Mauricio P Pinto; Ibeth Gonzalez; Barbara Oliva; Sumie Kato; Mauricio A Cuello; Carol A Lange; Gareth I Owen
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

Review 4.  Reversible or irreversible remodeling in pulmonary arterial hypertension.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-11       Impact factor: 6.914

5.  Glycogen synthase kinase-3 negatively regulates tissue factor expression in monocytes interacting with activated platelets.

Authors:  A Di Santo; C Amore; G Dell'Elba; S Manarini; V Evangelista
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

6.  Monocyte procoagulant responses to anthrax peptidoglycan are reinforced by proinflammatory cytokine signaling.

Authors:  Narcis Ioan Popescu; Alanson Girton; Tarea Burgett; Kessa Lovelady; K Mark Coggeshall
Journal:  Blood Adv       Date:  2019-08-27

7.  Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.

Authors:  Chloe C Milsom; Joanne L Yu; Nigel Mackman; Johann Micallef; G Mark Anderson; Abhijit Guha; Janusz W Rak
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes.

Authors:  P Minuz; M Degan; S Gaino; A Meneguzzi; V Zuliani; C L Santonastaso; P D Soldato; A Lechi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

Authors:  Philip A Marsden; Qin Ning; Laisum S Fung; Xioping Luo; Yue Chen; Michael Mendicino; Anand Ghanekar; Jeremy A Scott; Teresa Miller; Camie W Y Chan; Mathew W C Chan; Wei He; Reginald M Gorczynski; David R Grant; David A Clark; M James Phillips; Gary A Levy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

10.  Porcine endothelial cells cocultured with smooth muscle cells became procoagulant in vitro.

Authors:  Zhengyu Pang; Laura E Niklason; George A Truskey
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.